Particle Therapy Industry Overview

Global particle therapy market is projected to reach USD 1,004 million by 2027 from USD 677 million in 2022, growing at a CAGR of 8.2% from 2022 to 2027.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137

Market growth is driven by factors such as growing adoption of particle therapy in clinical trials and the increasing number of particle therapy centers worldwide. Emerging markets are China India, Brazil, and South Africa are showing lucrative growth opportunities to market.

Covid-19 Impact on Economic Scenario in Particle Therapy Market

Globally, the outbreak of COVID-19 has impacted every aspect of the medical device industry, including particle therapy devices. From region to region, there is considerable variation in the management of particle therapy procedures during the COVID-19 pandemic. The particle therapy market is expected to be impacted due to the temporary postponement of various elective surgeries as governments and authorities seek to ensure the availability of resources for COVID-19 patients.

Particle Therapy Market Segmentation

Pediatric cancer defined for the largest share in the particle therapy market by cancer type

Based on cancer type, the particle therapy market is segmented into prostate cancer. pediatric cancer, lung cancer, breast cancer, head & neck cancer, and other cancers. The pediatric cancer segment is holds the largest share of 24.8% of the particle therapy market in 2021 with CAGR of 10.4% during the forecast period.

Products such as cyclotron accounted for the largest share in the particle therapy market by product type

Based on products & services, the particle therapy market is segmented into products and services. In 2021, products are estimated to account for the largest share of 78.6% of the particle therapy market.

Based on system, multi-room systems holds the largest share in the particle therapy

Based on the system, the particle therapy market is segmented into single-room and multi-room particle therapy systems. The multi-room systems segment is expected to account for the largest share (67.8%) of the particle therapy market.

Particle Therapy Regional Outlook

  • North America
  • Europe
  • Asia pacific
  • Latin america
  • Middle east & Africa

Key Companies Profile & Market Share Insights

Prominent players in the particle therapy market include Varian Medical Systems, Inc. (US), IBA Worldwide (EU), Mevion Medical Systems (US), Provision Healthcare, LLC (US), Sumitomo Heavy Industries, Ltd. (Japan), Hitachi, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), Protom International, Inc. (US), Advanced Oncotherapy PLC. (EU), and Danfysik A/S (Denmark)

IBA is one of the leading players in the particle therapy market. Its Proton Therapy segment offers Proteus PLUS, a treatment room solution, and Proteus ONE, a single-room cancer treatment solution.

Order a free sample PDF of the Particle Therapy Market Intelligence Study, published by MarketsandMarkets.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

sales@marketsandmarkets.com